PainChek Statistics

Total Valuation

PainChek has a market cap or net worth of AUD 62.63 million. The enterprise value is 59.75 million.

Market Cap	62.63M
Enterprise Value	59.75M

Important Dates

The next estimated earnings date is Friday, August 29, 2025.

Earnings Date	Aug 29, 2025
Ex-Dividend Date	n/a

Share Statistics

PainChek has 1.84 billion shares outstanding. The number of shares has increased by 20.27% in one year.

Current Share Class	1.84B
Shares Outstanding	1.84B
Shares Change (YoY)	+20.27%
Shares Change (QoQ)	+6.16%
Owned by Insiders (%)	23.69%
Owned by Institutions (%)	n/a
Float	1.29B

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	20.69
PB Ratio	27.01
P/TBV Ratio	27.01
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.32
EV / Sales	19.74
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-7.64

Financial Position

The company has a current ratio of 1.80

Current Ratio	1.80
Quick Ratio	1.75
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -457.46% and return on invested capital (ROIC) is -285.91%.

Return on Equity (ROE)	-457.46%
Return on Assets (ROA)	-114.82%
Return on Invested Capital (ROIC)	-285.91%
Return on Capital Employed (ROCE)	-352.21%
Revenue Per Employee	n/a
Profits Per Employee	n/a
Employee Count	n/a
Asset Turnover	0.68
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +27.82% in the last 52 weeks. The beta is 0.31, so PainChek's price volatility has been lower than the market average.

Beta (5Y)	0.31
52-Week Price Change	+27.82%
50-Day Moving Average	0.04
200-Day Moving Average	0.03
Relative Strength Index (RSI)	36.12
Average Volume (20 Days)	3,060,597

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, PainChek had revenue of AUD 3.03 million and -8.17 million in losses. Loss per share was -0.01.

Revenue	3.03M
Gross Profit	856,586
Operating Income	-8.17M
Pretax Income	-8.17M
Net Income	-8.17M
EBITDA	-8.14M
EBIT	-8.17M
Loss Per Share	-0.01

Full Income Statement

Balance Sheet

The company has 2.88 million in cash and n/a in debt, giving a net cash position of 2.88 million or 0.00 per share.

Cash & Cash Equivalents	2.88M
Total Debt	n/a
Net Cash	2.88M
Net Cash Per Share	0.00
Equity (Book Value)	2.32M
Book Value Per Share	0.00
Working Capital	2.29M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -7.79 million and capital expenditures -29,676, giving a free cash flow of -7.82 million.

Operating Cash Flow	-7.79M
Capital Expenditures	-29,676
Free Cash Flow	-7.82M
FCF Per Share	-0.00

Full Cash Flow Statement

Margins

Gross margin is 28.30%, with operating and profit margins of -269.86% and -269.86%.

Gross Margin	28.30%
Operating Margin	-269.86%
Pretax Margin	-269.86%
Profit Margin	-269.86%
EBITDA Margin	-268.87%
EBIT Margin	-269.86%
FCF Margin	n/a

Dividends & Yields

PainChek does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-20.27%
Shareholder Yield	n/a
Earnings Yield	-13.04%
FCF Yield	-12.48%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

PainChek has an Altman Z-Score of -9.85 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-9.85
Piotroski F-Score	3